Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States

Background: The Intercept Blood System (IBS) for platelets has been developed to reduce pathogen transmission risks during transfusions. Objective: This study was a comprehensive economic analysis of the cost-effectiveness of using the IBS for single-donor apheresis platelets (AP) and random-donor p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Ther
Hauptverfasser: Bell, Christopher E., Botteman, Marc F., Gao, Xin, Weissfeld, Joel L., Postma, Maarten J., Pashos, Chris L., Triulzi, Darrell, Staginnus, Ulf
Format: Artigo
Sprache:Inglês
Veröffentlicht: Published by Elsevier Inc. 2003
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7133650/
https://ncbi.nlm.nih.gov/pubmed/14604745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0149-2918(03)80288-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge